Patients diagnosed with SVT via ultrasound may have higher risk for VTE
Patients who buy Plavix may reduce their risk of experiencing a stroke, a condition that is caused by severe clotting that blocks blood flow to the brain.
Patients who buy Plavix may reduce their risk of experiencing a stroke, a condition that is caused by severe clotting that blocks blood flow to the brain. Although superficial vein thrombosis (SVT) tends to clear away on its own without treatment, individuals who have it are up to six times more likely to develop a dangerous condition called venous thromboembolism (VTE).
According to a paper published in the current issue of Blood, the official journal of the American Society of Hematology, patients who are diagnosed with SVT with ultrasound had a higher risk of developing VTE.
However, researchers pointed out that it is still unclear whether those clinically diagnosed with SVT develop the life-threatening illness.
"While current literature defines 'real' SVT as a disorder diagnosed both clinically and through an ultrasound, in reality, clinical practice does not necessarily follow this model," said senior researcher Suzanne C. Cannegieter of the Leiden University Medical Center in the Netherlands. "In fact, most physicians are able to identify SVT by the presence of a red, painful, palpable cord in the course of a patient's superficial vein, for which additional testing with ultrasound is not necessary."
|
